Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories
The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, …
All Posts
Advancing Cell-free Biocomputing
Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …
From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …
The Power of STB CLOUD in Remote AI Drug Discovery
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …
AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning
The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …
RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment
Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and …
Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …
Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements
In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and …
Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies
Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American …
Reimagining Genomics Data Analysis: Interview with Paolo Di Tommaso from Seqera Labs
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer …
Ultima Genomics and Genome Insight Leverage Artificial Intelligence to Offer Cost-Effective Whole Genome Sequencing for Cancer Patients
Ultima Genomics and Genome Insight have forged a partnership with the objective of providing cost-effective whole genome sequencing solutions to …
FDA Collaborates with Cerner Enviza and John Snow Labs to Harness AI and EHR Data Analytics for Pharmacovigilance
Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support …